BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3873899)

  • 1. In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains.
    Sweeney KG; Verghese A; Needham CA
    Antimicrob Agents Chemother; 1985 Apr; 27(4):499-502. PubMed ID: 3873899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983.
    Forsgren A; Walder M
    Acta Otolaryngol Suppl; 1984; 407():43-9. PubMed ID: 6437134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of Branhamella catarrhalis to oral antibiotics.
    Kallings I
    Drugs; 1986; 31 Suppl 3():17-22. PubMed ID: 3488193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis.
    Doern GV; Siebers KG; Hallick LM; Morse SA
    Antimicrob Agents Chemother; 1980 Jan; 17(1):24-9. PubMed ID: 6766292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.
    Alvarez S; Jones M; Holtsclaw-Berk S; Guarderas J; Berk SL
    Antimicrob Agents Chemother; 1985 Apr; 27(4):646-7. PubMed ID: 3873905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serotype distribution and drug resistance of
    Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
    Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibiotic sensitivity of Branhamella catarrhalis isolated from respiratory tract infections].
    Nishioka K; Ida S; Takishima T
    Jpn J Antibiot; 1984 Jul; 37(7):1289-93. PubMed ID: 6567671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiresistance plasmid from commensal Neisseria strains.
    Pintado C; Salvador C; Rotger R; Nombela C
    Antimicrob Agents Chemother; 1985 Jan; 27(1):120-4. PubMed ID: 3885843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
    Crider SR; Colby SD
    Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacteriostatic and bactericidal effect of penicillins, cephalosporins, aminoglycosides and ampicillin plus gentamicin compared to trimethoprim plus sulfamethoxazole on "Listeria monocytogenes" (author's transl)].
    Boisivon A
    Ann Microbiol (Paris); 1980; 131B(3):267-76. PubMed ID: 6781393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
    Baker CN; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1980 Apr; 17(4):757-61. PubMed ID: 6249195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disk diffusion susceptibility of Branhamella catarrhalis and relationship of beta-lactam zone size to beta-lactamase production.
    Luman I; Wilson RW; Wallace RJ; Nash DR
    Antimicrob Agents Chemother; 1986 Nov; 30(5):774-6. PubMed ID: 3492178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity of Branhamella catarrhalis.
    Schreiner A
    Acta Otolaryngol Suppl; 1984; 407():40-2. PubMed ID: 6333774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disk diffusion susceptibility testing of Branhamella catarrhalis with ampicillin and seven other antimicrobial agents.
    Doern GV; Tubert T
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1519-23. PubMed ID: 3124732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Branhamella catarrhalis to sulphamethoxazole and trimethoprim.
    Riley TV; Digiovanni C; Hoyne GF
    J Antimicrob Chemother; 1987 Jan; 19(1):39-43. PubMed ID: 3494008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disk diffusion antimicrobial susceptibility testing of members of the family Legionellaceae including erythromycin-resistant variants of Legionella micdadei.
    Dowling JN; McDevitt DA; Pasculle AW
    J Clin Microbiol; 1984 Jun; 19(6):723-9. PubMed ID: 6565706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830).
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1989; 12(6):495-510. PubMed ID: 2560422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility and beta-lactamase characterization of Branhamella catarrhalis isolates from 1983/1984 and 1988.
    Christensen JJ; Keiding J; Bruun B
    APMIS; 1990 Nov; 98(11):1039-44. PubMed ID: 2123390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics.
    Liñares J; Perez JL; Garau J; Murgui L; Martín R
    J Antimicrob Chemother; 1984 Apr; 13(4):353-9. PubMed ID: 6609919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.